search
Back to results

Effects of a Food Preservative on Glucose Homeostasis

Primary Purpose

Overweight

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
benzoate containing test drinks
non sodium benzoate containing test drinks
Sponsored by
Boston Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Overweight focused on measuring diabetes, benzoic acid, benzoate, soda, soft drink, preservative, blood sugar

Eligibility Criteria

18 Years - 35 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Men and women age 18-35
  • BMI 25-30

Exclusion Criteria:

  • Diabetes Mellitus (fasting Blood Glucose ≥ 126mg/dl)
  • Exercise more than 60 minutes more that 4 times a week
  • Major medical illness
  • Medications or supplements that can influence glucose metabolism
  • Large fluctuations in weight (>5% over the past 6 months)
  • Currently following a weight loss program
  • Consumption of more than 24 ounces of soda per day (defined as sugar- or artificially sweetened beverages, e.g. colas or fruit punches, excluding hot tea and coffee)
  • Allergy or intolerance to sodium benzoate
  • Nicotine use
  • Illicit substance use
  • Women with irregular menstrual cycles, or who are pregnant or breastfeeding

Sites / Locations

  • Massachusetts General Hospital
  • Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

sodium benzoate containing

non sodium benzoate containing

Arm Description

Outcomes

Primary Outcome Measures

Blood glucose area under the curve (AUC)
Plasma glucose will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.

Secondary Outcome Measures

Insulin AUC
Serum Insulin will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.
Glucagon AUC
Plasma Glucagon will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.
Metabolite Profiles
Metabolite analysis will be performed on blood samples at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.

Full Information

First Posted
August 10, 2010
Last Updated
September 28, 2012
Sponsor
Boston Children's Hospital
Collaborators
Massachusetts General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01179945
Brief Title
Effects of a Food Preservative on Glucose Homeostasis
Official Title
Effects of a Food Preservative on Glucose Homeostasis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2012
Overall Recruitment Status
Completed
Study Start Date
August 2010 (undefined)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
December 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Boston Children's Hospital
Collaborators
Massachusetts General Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators propose to examine the effects of the common food preservative sodium benzoate on blood glucose and related hormones and metabolites. If an effect is demonstrated, patients with increased diabetes risk could be counseled to avoid this preservative.
Detailed Description
Soft drink consumption has been repeatedly implicated in the development of type 2 diabetes (T2DM). Interestingly, epidemiology studies have yielded inconsistent results. Some studies identify sugar-sweetened beverages as the culprit, whereas others point towards artificially-sweetened beverages. Beyond differences in methodology, these conflicting reports raise the question whether another ingredient common to both sugar and artificially-sweetened soft drinks, such as a preservative, might play a role. Benzoate salts are widely used preservatives in products such as sodas, canned goods, and pharmaceuticals. Interestingly, there is published evidence that sodium benzoate and its metabolite hippurate can affect pancreatic islet function and impair glucose tolerance. However, the effects of oral sodium benzoate at concentrations typically used in our diet on glucose homeostasis have not been systematically studied. Here, we propose to close this knowledge gap. We will recruit 15 healthy, overweight volunteers, age 18-35. Each subject will receive 4 interventions: an oral glucose challenge 1) with and 2) without 0.1% benzoic acid, and a drink of water 3) with and 4) without 0.1% benzoic acid. Blood samples will be analyzed for glucose, insulin, glucagon, and a panel of approximately 300 different metabolites at baseline and serially for 2 hours after each intervention. Factorial analysis of variance will be performed to determine the effects of benzoic acid in the presence and absence of glucose, and interactions between glucose and benzoate. The planned sample size of 15 will provide 80% power to detect an effect-size of 0.16 standard-deviations in outcome measures, and an interaction-effect of 0.33 standard-deviations, with a critical value p=0.05. If we find through this study that sodium benzoate significantly affects glucose tolerance, the public health implications would be great. High level, frequent consumption might cause diseases associated with insulin resistance, chiefly T2DM. Furthermore, its presence in OGTT testing solutions could provide misleading results.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight
Keywords
diabetes, benzoic acid, benzoate, soda, soft drink, preservative, blood sugar

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
sodium benzoate containing
Arm Type
Experimental
Arm Title
non sodium benzoate containing
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
benzoate containing test drinks
Intervention Description
Subjects will consume 500ml of water with 0.5 grams of sodium benzoate, followed by a solution of 75g sugar in 500ml water with 0.5 grams sodium benzoate 3 hours later. Each solution will be consumed over 5 minutes.
Intervention Type
Other
Intervention Name(s)
non sodium benzoate containing test drinks
Intervention Description
Subjects will consume 500ml of water followed by a solution of 75g sugar in 500ml water 3 hours later. Each solution will be consumed over 5 minutes.
Primary Outcome Measure Information:
Title
Blood glucose area under the curve (AUC)
Description
Plasma glucose will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.
Time Frame
120 minutes post ingestion
Secondary Outcome Measure Information:
Title
Insulin AUC
Description
Serum Insulin will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.
Time Frame
120 minutes
Title
Glucagon AUC
Description
Plasma Glucagon will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.
Time Frame
120 minutes
Title
Metabolite Profiles
Description
Metabolite analysis will be performed on blood samples at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution, and area under the curve will be calculated.
Time Frame
120 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Men and women age 18-35 BMI 25-30 Exclusion Criteria: Diabetes Mellitus (fasting Blood Glucose ≥ 126mg/dl) Exercise more than 60 minutes more that 4 times a week Major medical illness Medications or supplements that can influence glucose metabolism Large fluctuations in weight (>5% over the past 6 months) Currently following a weight loss program Consumption of more than 24 ounces of soda per day (defined as sugar- or artificially sweetened beverages, e.g. colas or fruit punches, excluding hot tea and coffee) Allergy or intolerance to sodium benzoate Nicotine use Illicit substance use Women with irregular menstrual cycles, or who are pregnant or breastfeeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David S Ludwig, MD, PhD
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Vamsi Mootha, MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Belinda S Lennerz, MD, PhD
Organizational Affiliation
Boston Children's Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Scott Vafai, MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02101
Country
United States
Facility Name
Children's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effects of a Food Preservative on Glucose Homeostasis

We'll reach out to this number within 24 hrs